Ansell (ANN) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
29 Oct, 2025Opening remarks and agenda
Meeting held in hybrid format, with clear instructions for voting and questions provided to all attendees.
CEO Neil Salmon addressed attendees, setting the stage for the meeting and outlining the agenda.
Quorum confirmed, voting opened on all items, and procedural guidelines for shareholder engagement emphasized.
Board members, CEO, and auditor introduced, with roles in the meeting clarified.
Financial performance review
FY2025 adjusted earnings per share reached $1.261, up from $1.055 in FY2024, near the top of guidance.
Group sales reached $2,003.3m, up 23.7%, with 9.4% growth in Healthcare and 5.6% in Industrial segments.
EBIT before significant items was $282 million, up over 40% year-on-year, driven by higher sales, improved manufacturing, and APIP savings.
Net Debt/EBITDA at 1.6x, reflecting strong financial discipline.
Strategic initiatives and plans
Accelerated Productivity Investment Program (APIP) completed organizational and manufacturing changes, delivering $47 million in FY2025 savings and targeting $50 million in FY2026.
KBU integration completed ahead of schedule, with synergy targets for FY2027 increased from $10 million to $15 million.
ERP system unification to commence in H2 FY2026, expected to enhance digital capabilities and productivity.
Focus on scaling KBU's RightCycle recycling service and consolidating brands.
Ongoing R&D to increase recyclability and biodegradability of products, with expansion of the Right Cycle recycling program.
Latest events from Ansell
- Double-digit growth, raised EPS guidance, and strong KBU integration highlight H1 FY25.ANN
H1 20258 Jul 2026 - Improved margins, strong cash flow, and KBU acquisition drive growth amid ongoing risks.ANN
AGM 20248 Jul 2026 - Margin gains, strong cash flow, and KBU integration support FY25 organic growth.ANN
H2 20241 Jun 2026 - Robust FY25 growth, successful KBU integration, and price actions offset US tariffs; positive FY26 outlook.ANN
H2 20251 Jun 2026 - Double-digit earnings growth and margin expansion achieved, with FY26 EPS guidance maintained.ANN
H1 20261 Jun 2026